cbdMD Depreciation & Amortization 2011-2026 | YCBD

Annual Depreciation & Amortization cbdMD

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
452 K	404 K	949 K	1.02 M	721 K	290 K	223 K	71.3 K	44.9 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.02 M	44.9 K	464 K

Quarterly Depreciation & Amortization cbdMD

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
54.2 K	-	191 K	191 K	107 K	-	173 K	173 K	111 K	-	-	-	100 K	770 K	159 K	323 K	341 K	720 K	247 K	241 K	233 K	499 K	287 K	233 K	113 K	272 K	171 K	113 K	64.4 K	170 K	117 K	64.4 K	61.1 K	42.2 K	27.6 K	61.1 K	9.19 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
770 K	9.19 K	201 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.08	1.89 %	$ 116 M	Canada
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Evolus EOLS	7.51 M	$ 5.59	35.35 %	$ 360 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.58	5.64 %	$ 10.1 M	China
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.67	-19.87 %	$ 51.6 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Harrow Health HROW	1.32 M	$ 39.22	1.59 %	$ 1.44 B	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Emergent BioSolutions EBS	125 M	$ 8.77	-	$ 449 M	USA
Assertio Holdings ASRT	28.2 M	$ 12.07	1.47 %	$ 857 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.63	0.09 %	$ 2.05 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Organogenesis Holdings ORGO	13.6 M	$ 2.87	-	$ 378 M	USA
Perrigo Company plc PRGO	338 M	$ 11.69	-	$ 1.62 B	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
TherapeuticsMD TXMD	922 K	$ 2.16	-2.7 %	$ 22.6 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Veru VERU	268 K	$ 2.51	-0.4 %	$ 339 M	USA
Viatris VTRS	2.74 B	$ 14.71	-1.21 %	$ 17.7 B	USA
Rockwell Medical RMTI	1.44 M	$ 0.89	-0.83 %	$ 20.8 M	USA
Pacira BioSciences PCRX	78.8 M	$ 22.86	-	$ 1.06 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.77	2.14 %	$ 144 M	USA
SCYNEXIS SCYX	580 K	$ 0.78	3.09 %	$ 38.9 M	USA
Solid Biosciences SLDB	2.46 M	$ 6.14	3.02 %	$ 251 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.8	1.82 %	$ 3.47 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Tilray TLRY	35.7 M	$ 7.3	-0.82 %	$ 4.51 B	Canada
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA